Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 97,181	$ 117,453
Prepaid expenses	812	2,142
Total current assets	97,993	119,595
Property and equipment, net	5,352	4,612
Operating lease right-of-use assets	999	0
Total assets	104,344	124,207
Current liabilities:
Accounts payable	1,440	1,080
Related party payable	30	126
Accrued expenses	3,221	1,434
Operating lease liability, current portion	658
Total current liabilities	5,349	2,640
Operating lease liability, net current portion	341	0
Total liabilities	5,690	2,640
Commitments and contingencies (Note 10)
Stockholders' equity / members' deficit:
Preferred stock, $0.0001 par value - 20,000 shares authorized; none issued and outstanding as of June 30, 2022 and December 31, 2021	0	0
Additional Paid in Capital	69,986	55,737
Accumulated deficit	(22,178)	(8,331)
Total stockholders' equity attributable to Rani Therapeutics Holdings, Inc.	47,813	47,411
Non-controlling interest	50,841	74,156
Total stockholders' equity	98,654	121,567
Total liabilities and stockholders' equity	104,344	124,207
Common Class A [Member]
Stockholders' equity / members' deficit:
Common stock, value	2	2
Common Class B [Member]
Stockholders' equity / members' deficit:
Common stock, value	3	3
Common Class C [Member]
Stockholders' equity / members' deficit:
Common stock, value	$ 0	$ 0